Evidence map›Paper›PMID 37092548›Full record

ArticleJCI insight2023

FRC transplantation restores lymph node conduit defects in laminin α4-deficient mice.

Lushen Li, Long Wu, Allison Kensiski, Jing Zhao, Marina W Shirkey, Yang Song, Wenji Piao, Tianshu Zhang, Zhongcheng Mei, Samuel J Gavzy and 8 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Lushen LiDepartment of Surgery, and.
Long WuDepartment of Surgery, and.
Allison KensiskiDepartment of Surgery, and.
Jing ZhaoTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Marina W ShirkeyDepartment of Surgery, and.
Yang SongInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wenji PiaoDepartment of Surgery, and.
Tianshu ZhangDepartment of Surgery, and.
Zhongcheng MeiDepartment of Surgery, and.
Samuel J GavzyDepartment of Surgery, and.
Bing MaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Vikas SaxenaDepartment of Surgery, and.
Young S LeeDepartment of Surgery, and.
Yanbao XiongDepartment of Surgery, and.
Xiaofei LiTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Xiaoxuan FanFlow Cytometry Shared Service, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
Reza AbdiTransplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jonathan S BrombergDepartment of Surgery, and.
University of Maryland, Baltimore · USBrigham and Women's Hospital · USSidney Kimmel Comprehensive Cancer Center · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Vu H. Duong · 2008 to 2026
$51.0M
Reshaping lymph node stroma for transplant toleranceP01AI153003 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Reza Abdi · 2020 to 2026
$9.3M
Induction and Migration of Regulatory T Cells: Role of LymphotoxinR01AI062765 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROMBERG, JONATHAN S · 2005 to 2019
$5.6M
Lymph Node Structure and Function in Tolerance: Role of LamininsR01AI114496 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROMBERG, JONATHAN S · 2015 to 2024
$4.2M
Targeted immune therapies in heart transplantationR35HL166640 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Reza Abdi · 2023 to 2026
$4.1M
Regulatory T Cells and Lymphatic Endothelial Cells: Regulatory Interactions for Migration and SuppressionR37AI062765 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Jonathan S Bromberg · 2021 to 2026
$2.9M
A novel approach to delivering therapeutics in heart transplantationR01HL145813 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2019 to 2022
$2.6M
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcomeR01HL148672 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BROMBERG, JONATHAN S, MA, BING · 2019 to 2022
$2.3M
IRI, innate immunity and transplant rejectionR01AI156084 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2021 to 2025
$2.3M
PI3K-gamma regulates T cell mediated alloimmunityR01HL141815 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ABDI, REZA · 2018 to 2021
$1.6M
NCI NIH HHS P30 CA134274NHLBI NIH HHS R01 HL141815NHLBI NIH HHS R01 HL145813NHLBI NIH HHS R01 HL148672NHLBI NIH HHS R35 HL166640NIAID NIH HHS P01 AI153003NIAID NIH HHS R01 AI062765NIAID NIH HHS R01 AI114496NIAID NIH HHS R01 AI156084NIAID NIH HHS R37 AI062765
6 · The paper itself

Abstract

Fibroblastic reticular cells (FRCs) play important roles in tolerance by producing laminin α4 (Lama4) and altering lymph node (LN) structure and function. The present study revealed the specific roles of extracellular matrix Lama4 in regulating LN conduits using FRC-specific KO mouse strains. FRC-derived Lama4 maintained conduit fiber integrity, as its depletion altered conduit morphology and structure and reduced homeostatic conduit flow. Lama4 regulated the lymphotoxin β receptor (LTβR) pathway, which is critical for conduit and LN integrity. Depleting LTβR in FRCs further reduced conduits and impaired reticular fibers. Lama4 was indispensable for FRC generation and survival, as FRCs lacking Lama4 displayed reduced proliferation but upregulated senescence and apoptosis. During acute immunization, FRC Lama4 deficiency increased antigen flow through conduits. Importantly, adoptive transfer of WT FRCs to FRC Lama4-deficient mice rescued conduit structure, ameliorated Treg and chemokine distribution, and restored transplant allograft acceptance, which were all impaired by FRC Lama4 depletion. Single-cell RNA sequencing analysis of LN stromal cells indicated that the laminin and collagen signaling pathways linked crosstalk among FRC subsets and endothelial cells. This study demonstrated that FRC Lama4 is responsible for maintaining conduits by FRCs and can be harnessed to potentiate FRC-based immunomodulation.

Indexed as

Endothelial CellsLamininAnimalsChemokinesLymph NodesMiceSignal TransductionChemokinesLamininImmunologyLamininTolerance

Identifiers

PMID37092548
PMCPMC10243809
OpenAlexW4366777337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.